Founder, DEKA Research and Development Corporation
Assoc. Prof., Dept. of Cell Biology, Scripps Research Institute
Vice President, Kauffman Foundation
Co-Founder and CEO, Modumental
Managing Director, CommonAngels
Vice Provost, TechTransfer, University of Washington
Managing Partner, Rho Capital Partners and Rho Ventures
Lecturer, MIT
|
Charles River Laboratories International (NYSE:CRL), a Wilmington, MA-based provider of drug development services, announced the opening of a 60,000-square-foot pre-clinical facility in Shanghai. The company says that the facility is intended to support the global drug-development needs of its clients.
San Francisco · 6/7/12
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
